UNSPSC 51263308: Ericolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38R2P4PIEI. European Medicines Agency schedules Ericolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06599MIG. Ericolol generally arises in the molecular formula C18H24CLNO3.

UNSPSC 51263308 Ericolol is a Commodity code that state and local governments are using to procure naloxone and drug deactivation systems for community health and harm-reduction initiatives. The code appears in recent solicitations focused on bulk purchase and recurring delivery of naloxone and companion drug-disposal products to support opioid-response and public-health programs. Issuing bodies soliciting under this code include county health departments and state health and human services agencies; Seminole County, Florida and the Texas Health and Human Services Commission have posted recent opportunities under related pharmaceutical and drug-management procurement activity.

Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with bids due July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor information on direct-to-manufacturer prescription and pharmaceutical delivery models that may inform future state pharmacy benefit procurement. These represent exploratory and active procurement phases in Florida and Texas, respectively, suggesting ongoing demand for naloxone-supply contracts and related pharmaceutical-access programs across state and county health systems.